REX vs VRTX · P/E 15, rev $642.5M vs P/E 30, rev $12.00B
REX American Resources Corporation (REX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
REX currently screens at market cap $1.43B and trailing P/E 15.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the REX and VRTX stock pages for the full models.
Not investment advice.